| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 04/22/2009 | CN100479817C The use of Nifuratel for preparing medicine for treating oral cavity infection |
| 04/22/2009 | CN100479804C Tibet medicine lamivphlomis root injection preparation and preparing method thereof |
| 04/22/2009 | CN100479674C Vanilla-ginger red tea and preparation process thereof |
| 04/22/2009 | CN100479673C Vanilla-cogongrass rhizome tea and preparation process thereof |
| 04/21/2009 | US7521471 CB1cannabinoid receptor antagonists; e.g. 5-(4-chlorophenyl)-4-cyano-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-1H-pyrazole-3-carboxamide; various psychological, neurodegenerative, pain and cardiovascular disorders |
| 04/21/2009 | US7521455 Histamine H3 receptor antagonist or inverse agonist activity; metabolic diseases, circulatory diseases, or nervous system diseases; e.g. 3-(4-((1-cyclobutyl-4-piperidinyl)oxy)phenyl)-2-ethylpyrido(2,3-d)pyrimidin-4(3H)-one |
| 04/21/2009 | US7521450 Inhibitors of kinases |
| 04/21/2009 | US7521423 Exendin pharmaceutical compositions |
| 04/21/2009 | US7521419 Peptide-based compounds |
| 04/21/2009 | US7521234 Mammalian immortalized liver cell |
| 04/21/2009 | US7521052 Administering an effective amount of an anti-IL-6 receptor antibody (anti-IL-6R antibody) and an effective amount of methotrexate (MTX) for therapy of rheumatoid arthritis |
| 04/21/2009 | CA2400317C Improved paste formulations |
| 04/21/2009 | CA2362003C Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 04/21/2009 | CA2356263C Aminopyrazole derivatives |
| 04/21/2009 | CA2272963C Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whiteningand/or cleaning of an individual's teeth |
| 04/21/2009 | CA2182949C Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 04/21/2009 | CA2157855C Benzoylguanidines substituted by heterocyclic n-oxide, process for their preparation, their use as a medicament or diagnostic agent, medicament containing them and intermediate products for their preparation |
| 04/21/2009 | CA2115927C Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 04/16/2009 | WO2009049239A1 Use of adsorbent carbon microspheres to treat pouchitis |
| 04/16/2009 | WO2009049013A2 Cholera vaccines |
| 04/16/2009 | WO2009048934A2 Probiotics for use in relieving symptoms associated with gastrointestinal disorders |
| 04/16/2009 | WO2009048864A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | WO2009048603A1 Methods and kits for the treatment of diverticular conditions |
| 04/16/2009 | WO2009048289A2 Pharmaceutical composition for treating hepatitis c virus infection comprising hmg-coa reductase inhibitor and bile acid |
| 04/16/2009 | WO2009048073A1 Method of coating granules |
| 04/16/2009 | WO2009047904A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient |
| 04/16/2009 | WO2009047903A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | WO2009046853A1 Use of intermedin 47 peptide as a therapeutic agent |
| 04/16/2009 | WO2009046852A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/16/2009 | WO2008108380A3 Pyrrole compounds |
| 04/16/2009 | WO2005042727A3 Methods of organ regeneration |
| 04/16/2009 | US20090099373 Compositions enriched in anthocyanins |
| 04/16/2009 | US20090099223 Methods of treating hormone-related conditions using thio-oxindole derivatives |
| 04/16/2009 | US20090099208 Novel guanidine derivatives and their medical use |
| 04/16/2009 | US20090099206 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | US20090099185 P38 Map Kinase Inhibitors |
| 04/16/2009 | US20090099164 Phenylaminopropanol Derivatives and Methods of Their Use |
| 04/16/2009 | US20090099156 Heterocyclic Compounds as Ccr2b antagonists |
| 04/16/2009 | US20090099139 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use |
| 04/16/2009 | US20090099071 Sugar chain-containing albumin, production method thereof and use thereof |
| 04/16/2009 | US20090098569 Novel PGC-1 Isoforms and Uses Therefor |
| 04/16/2009 | US20090098528 Method for determining early HCV seroconversion |
| 04/16/2009 | US20090098157 Helicobacter Pylori Vaccination |
| 04/16/2009 | US20090098153 Activation of HCV-specific T cells |
| 04/16/2009 | US20090098117 Composition comprising and method of using angiopoietin-like protein 3 angptl3 |
| 04/16/2009 | US20090098088 Methods And Kits For The Treatment Of Diverticular Conditions |
| 04/16/2009 | US20090098087 Method of treating lactose intolerance using genetically engineered bacteria |
| 04/16/2009 | DE202009000862U1 Dosiereinheit und Zusammensetzung zur Behandlung von entzündlichen Erkrankungen des Mund- und Rachenraums Dosing and composition for the treatment of inflammatory diseases of the mouth and throat |
| 04/16/2009 | DE202009000378U1 FF-Nahrungsergänzungsmittel FF supplements |
| 04/16/2009 | CA2702356A1 Pharmaceutical formulation comprising a proton pump inhibitor for the treatment of gastrointestinal conditions independent of food intake |
| 04/16/2009 | CA2702293A1 Probiotics for use in relieving symptoms associated with gastrointestinal disorders |
| 04/16/2009 | CA2702221A1 Methods and kits for the treatment of diverticular conditions |
| 04/16/2009 | CA2702023A1 Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient |
| 04/16/2009 | CA2701904A1 Solid forms of (s)-2-amino-3-(4-(2-amino-6-((r)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid and methods of their use |
| 04/16/2009 | CA2701880A1 Prophylactic or therapeutic agent for inflammatory disease comprising thymidine phosphorylase inhibitor as active ingredient |
| 04/16/2009 | CA2699169A1 Therapeutic uses of intermedin 47 and 53 peptides |
| 04/15/2009 | EP2048505A2 Method for early recognition of the seroconversion of an antibody to hepatitis C |
| 04/15/2009 | EP2048228A2 Human liver progenitors |
| 04/15/2009 | EP2048150A1 Benzyl phenyl glucopyranoside derivative |
| 04/15/2009 | EP2048145A1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof |
| 04/15/2009 | EP2048142A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof |
| 04/15/2009 | EP2047863A1 Preventive or remedy for inflammatory disease |
| 04/15/2009 | EP2047851A1 Drug formulation containing fibrate medicament and process for producing the same |
| 04/15/2009 | EP2046803A1 Imidazothiazole derivatives as mark inhibitors |
| 04/15/2009 | EP2046776A2 Methods and apparatus for identifying subject matter in view data |
| 04/15/2009 | EP2046740A1 Compounds having crth2 antagonist activity |
| 04/15/2009 | EP2046737A2 2-methylene-1 alpha,25-dihydroxy-19,21-dinorvitamin d3 analogs and uses thereof |
| 04/15/2009 | EP2046360A2 Herbal compositions for the treatment of diseases of the oral cavity |
| 04/15/2009 | EP2046352A1 Fermented milk product and use thereof |
| 04/15/2009 | EP2046349A1 Treatment of excessive neovascularization |
| 04/15/2009 | EP2046324A2 Treatment and prevention mucositis by anthocyanidin derivatives |
| 04/15/2009 | EP2046319A2 Cholecystokinin-1 (cck1) receptor antagonists in the treatment of gastrointestinal and related disorders |
| 04/15/2009 | EP2046135A2 Polyphenol/peptide composition and use thereof for promoting gastric health |
| 04/15/2009 | EP2003130A9 Novel pyridine derivative having anti-helicobacter pylori activity |
| 04/15/2009 | EP1719773B1 Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| 04/15/2009 | EP1551763B1 Method for the preparation of a silicic acid comprising extrudate, said extrudate, its use and a pharmaceutical composition comprising the said extrudate |
| 04/15/2009 | EP1531832B1 Therapeutic compositions for use in prophylaxis or treatment of diarrheas |
| 04/15/2009 | EP1363635B1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 04/15/2009 | EP1311532B1 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 04/15/2009 | EP1258251B1 Compositions for preventing and treating digestive diseases |
| 04/15/2009 | EP1024805B1 Use of coumarin derivatives for the treatment of liver and pancreatic disorders |
| 04/15/2009 | CN101410396A Chromane derivatives |
| 04/15/2009 | CN101410127A Intraorally rapidly disintegrating tablet |
| 04/15/2009 | CN101410110A Varenicline standards and impurity controls |
| 04/15/2009 | CN101410107A MIF inhibitors |
| 04/15/2009 | CN101407792A Preparation of pit viper bioactivity enzyme |
| 04/15/2009 | CN101407534A 2'-fluoro-4'-substituted-nucleoside analogue and use thereof |
| 04/15/2009 | CN101407513A Method for synthesizing nucleoside analogue |
| 04/15/2009 | CN101407468A Novel method for synthesizing aclatonium napadisilate |
| 04/15/2009 | CN101406699A Method for preparing lyophilized hepatitis A attenuated live vaccine using cell factory |
| 04/15/2009 | CN101406692A Vaccine composition containing transforming growth factor alpha |
| 04/15/2009 | CN101406689A Method for producing liver-boosting capsule containing glutathione and other nine ingredients |
| 04/15/2009 | CN101406687A Chinese medicine oral powder for treating gastropathy |
| 04/15/2009 | CN101406683A Chinese medicine compound and preparation method thereof |
| 04/15/2009 | CN101406677A Medicinal liquor having function for warming and invigorating kidney yang |
| 04/15/2009 | CN101406676A Soft capsule for treating fatty liver and preparation method thereof |
| 04/15/2009 | CN101406675A Medicine for treating hepatitis B |
| 04/15/2009 | CN101406668A Chinese medicinal composition for treating headache and dizzy, and preparation method thereof |
| 04/15/2009 | CN101406665A Chinese medicament preparation for discharging calculus in vivo |
| 04/15/2009 | CN101406661A Compound medicament for treating bacterial enteritis of aquatic livestock |